R&D
12 Questions with Marie Teil
Sponsored

12 Questions With Marie Teil

Marie Teil is a pharmaceutical executive with over 20 years of experience in the healthcare field. She leads UCB's Women of Childbearing Age programme

Digital
Deep Dive Communications 2020

Deep Dive: Communications 2020

COVID-19 might have forced pharma to finally fully embrace digital comms, but it’s been a steep learning curve and expertise varies across the industry.

R&D
Dangerous data delays – a real-time problem

Dangerous data delays – a real-time problem

Delayed clinical trial data delivery is a growing problem for pharmaceutical companies and one that can have catastrophic consequences for the development of their promising pipeline candid

Sales & Marketing

Sales & Marketing
women in discussion
Sponsored

Company Profile: Inizio Ignite

Inizio Ignite is the global advisory partner for health and life sciences, encompassing connected expertise across its ecosystem.

Sales & Marketing
AI-powered decision engine visual
Sponsored

Solution Spotlight: Medscape One

Medscape One (M1) is a sophisticated, AI-powered decision engine designed to redefine HCP engagement.

Digital

Market Access

Editor's Picks

  1. 'Seismic shift' as obesity overtakes cancer for R&D returns
  2. Bayer returns to M&A with $2.45bn Perfuse Therapeutics deal
  3. Lilly inflates US facility investment spending by $4.5bn
  4. Roche buys AI-powered diagnostics player PathAI
  5. Danco fights back after US court curbs abortion pill access

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

R&D
12 Questions with Marie Teil
Sponsored

12 Questions With Marie Teil

Marie Teil is a pharmaceutical executive with over 20 years of experience in the healthcare field. She leads UCB's Women of Childbearing Age programme

more